Maximizing The Potential Of Cell Therapy Products With Innovative Biopreservation Solutions

By Mira Genser-Nir, Meital Gury Ben-Ari, Anat Vishlitsky, Nyra Goldstein, Sharon Daniliuc, Marina Teverovsky, Yuliya-Yael Miropolski, Roni Hazan Brill, Natali Malka, Maria Sharovetsky, Bar Izkovich, Helen Rawsthorne, Phil Morton, and David Fiorentini

Cell preservation solutions that are both reliable and effective are essential for ensuring viable cell therapy products are transported from the manufacturing site to the point of care on time. However, cell preservation poses several challenges during shipping, such as low viability or recovery rates and the poor biocompatibility of current preservation solutions.

A range of cell preservation solutions has been developed to overcome these challenges. These include cryopreservation for the long-term storage of cells intended for use in clinical applications, hypothermic preservation for the transport and short-term storage of autologous cell therapy products, and recombinant human albumin, which enhances post-thaw viability and extends the therapeutic window. Continue reading to learn more about these all-in-one, ready-to-use, chemically-defined, and animal-component-free cryopreservation solutions.